Fig. 2From: A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function(a-c) Survival analyses of the derivation and validation set according to ASAR score. ASAR scores (cut-off = 4) offered similar predictive performance of overall survival in the internal and external validation set compared to that in the derivation setBack to article page